[1]
Sen, S. 2013. Canagliflozin (Invokana®): a First-in-Class Anti-diabetic Drug. Journal of Drug Delivery and Therapeutics. 3, 3 (May 2013), 145-146. DOI:https://doi.org/10.22270/jddt.v3i3.490.